Gary Ingenito, Chief Med. & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 24,000 shares at $22.67 ($545K) on 2024-11-27, disclosed to the SEC on 2024-11-29.
Open-market sale of $545k CPRX by Chief Med. & Reg. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.67 | 3,369 | $76K | 14.0% |
| 2 | $22.67 | 3,369 | $76K | 14.0% |
| 3 | $22.74 | 8,631 | $196K | 36.0% |
| 4 | $22.74 | 8,631 | $196K | 36.0% |
| Total | $22.72 avg | 24,000 | $545K | 100% |
| Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |
| CPRX | SELL | 2024-06-07 | $1.3M | — | Filing → |